Loading…
BioHarvest Sciences Inc. is projected to decline to $1.95 by 2027, a -10% move from its current price of $2.16. BHST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.08 | $2.16 | $2.24 | -0.05% |
| Aug 6 | $2.05 | $2.16 | $2.27 | -0.09% |
| Aug 7 | $2.03 | $2.16 | $2.30 | -0.14% |
| Aug 8 | $2.00 | $2.16 | $2.32 | -0.19% |
| Aug 9 | $1.99 | $2.15 | $2.34 | -0.23% |
| Aug 10 | $1.97 | $2.15 | $2.35 | -0.28% |
| Aug 11 | $1.96 | $2.15 | $2.37 | -0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.96 | $2.15 | $2.37 | -0.33% |
| Week 2 | $1.87 | $2.15 | $2.46 | -0.66% |
| Week 3 | $1.81 | $2.14 | $2.53 | -0.98% |
| Week 4 | $1.76 | $2.13 | $2.58 | -1.31% |
| Week 5 | $1.71 | $2.12 | $2.63 | -1.63% |
| Week 6 | $1.67 | $2.12 | $2.68 | -1.96% |
| Week 7 | $1.64 | $2.11 | $2.72 | -2.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services.
Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
BioHarvest Sciences Inc. (BHST) trades at $2.20 per share and has a market capitalization of $49.76M.
It ranks 4536 by market cap in the listed universe.
The multi-year forecast presents a price path with a 2026 average of $2.20, a 2030 average of $2.65, and a 2050 average of $6.69. Max values include $2.66 in 2026, $4.17 in 2030, and $14.21 in 2050, with corresponding ROIs of 0%, 20.9%, and 204.6% respectively. Sentiment shifts from Neutral in 2026 to Bullish in 2030, 2032, 2035, 2040, and 2050.
A major floor 48.8% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
The nearest ceiling, 50.9% above — a clean break opens room to run.
A major ceiling 104.6% above — clearing it would confirm fresh momentum.
Key BHST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.11 | Buy | $2.14 | Buy |
| MA 10 | $2.17 | Sell | $2.22 | Sell |
| MA 20 | $2.49 | Sell | $2.43 | Sell |
| MA 50 | $2.98 | Sell | $2.92 | Sell |
| MA 100 | $3.61 | Sell | $3.56 | Sell |
| MA 200 | $4.97 | Sell | $4.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.10 | Neutral |
| Stoch RSI (14) | 74.03 | Neutral |
| CCI (20) | -63.47 | Neutral |
| Williams %R (14) | -74.19 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -24.21 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 25.81 | Neutral |
| TRIX (15) | -1.29 | Sell |
| Awesome (5,34) | -0.60 | Sell |
| Ultimate (7,14,28) | 39.83 | Neutral |
| Momentum (10) | -0.54 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 2.16 | Buy |
| ADX (14) | 41.85 | Sell |
| ATR (14) | 0.08 | Info |
The near-term technical picture shows bearish sentiment, with RSI(14) at 30. The price is trading below key moving averages, with SMA50 at $3.05 and SMA200 at $5.07.
The 30-day range runs from $1.71 to $2.83, with a nearby support at $1.92 and a resistance at $3.31. This creates a defined short-term trading band and indicates potential downside if the support cannot hold, or a move toward resistance if buyers regain control.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.92 | $2.16 | $2.62 | 0% | Neutral | |
| $1.51 | $1.95 | $2.69 | -10% | Neutral | |
| $1.43 | $1.92 | $2.77 | -11% | Neutral | |
| $1.77 | $2.46 | $3.70 | +14% | Neutral | |
| $1.83 | $2.62 | $4.06 | +21% | Bullish | |
| $1.74 | $2.55 | $4.06 | +18% | Neutral | |
| $1.86 | $2.79 | $4.55 | +29% | Bullish | |
| $1.60 | $2.47 | $4.11 | +14% | Neutral | |
| $1.56 | $2.46 | $4.18 | +14% | Neutral | |
| $1.96 | $3.16 | $5.47 | +46% | Bullish | |
| $2.04 | $3.63 | $6.77 | +68% | Bullish | |
| $3.13 | $6.67 | $13.84 | +209% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.92 | $2.16 | $2.70 | +0.00% |
| September 2026 | $1.83 | $2.19 | $2.70 | +1.29% |
| October 2026 | $1.72 | $2.07 | $2.59 | -5.41% |
| November 2026 | $1.69 | $2.06 | $2.60 | -0.59% |
| December 2026 | $1.68 | $2.05 | $2.62 | -0.30% |
Click any year to see its month-by-month BHST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BioHarvest Sciences Inc.'s 2026 outlook centres on $2.16, within a $1.92 to $2.62 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHST could reach as high as $2.69, with a base case around $1.95 and support toward $1.51 — roughly -10% from $2.16. A consolidation phase looks the most probable path here.
Expect BHST to range from $1.43 to $2.77 through 2028. The $1.92 average target implies a -11% move from current prices. That is -2% versus the projected 2027 average. Price action looks broadly range-bound.
The BHST price prediction for 2029 points to an average of $2.46 (low $1.77, high $3.70) — a potential gain of +14% on today's $2.16. A consolidation phase looks the most probable path here.
In 2030, BHST is projected to trade between $1.83 and $4.06, averaging $2.62 — a potential gain of +21% from today's $2.16. That is up +6% on the projected 2029 average. Momentum favours further upside here.
BioHarvest Sciences Inc.'s 2031 outlook centres on $2.55, within a $1.74 to $4.06 range. That is -3% versus the projected 2030 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, BHST could reach as high as $4.55, with a base case around $2.79 and support toward $1.86 — roughly +29% from $2.16. Momentum favours further upside here.
Expect BHST to range from $1.60 to $4.11 through 2033. The $2.47 average target implies a +14% move from current prices. That is -12% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The BHST price prediction for 2034 points to an average of $2.46 (low $1.56, high $4.18) — a potential gain of +14% on today's $2.16. Price action looks broadly range-bound.
In 2035, BHST is projected to trade between $1.96 and $5.47, averaging $3.16 — a potential gain of +46% from today's $2.16. That is up +29% on the projected 2034 average. Buyers look set to stay in control over this stretch.
BioHarvest Sciences Inc.'s 2040 outlook centres on $3.63, within a $2.04 to $6.77 range. That is up +15% on the projected 2035 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2050, BHST could reach as high as $13.84, with a base case around $6.67 and support toward $3.13 — roughly +209% from $2.16. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHST today (≈ 462.962963 BHST) could be worth
$3,087.7
+$2,087.7 (+209%) by 2050 · US Dollar
Based on the average projected BHST price of $6.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHSTwould be worth at today's price.
$1,000 invested in BHST on Jul 31, 2025 (≈ 131.578949 BHST) would be worth
$284.21
-$715.79 (-71.6%) today · 0.28× · US Dollar
Based on a BHST entry price of $7.6 vs. today's $2.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.92 | $1,125 | +12.5% |
| 1 month ago | $2.91 | $742.27 | -25.8% |
| 3 months ago | $4.18 | $516.75 | -48.3% |
| 6 months ago | $4.81 | $449.06 | -55.1% |
| 1 year ago | $7.6 | $284.21 | -71.6% |
| All time (5.0y) ago | $11.9 | $181.51 | -81.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHST forecast.
Our base-case forecast reaches $4.30 around 2050.
Implied market cap at $4.30: $97.47M
The long-range forecast outlines a gradual price progression from a 2026 average of $2.20 toward higher levels, with a 2030 average of $2.65, a 2032 average of $2.83, a 2035 average of $3.22, a 2040 average of $3.70, and a 2050 average of $6.69. These steps are paired with progressively higher max values (e.g., $4.17 in 2030, $4.68 in 2032, $5.66 in 2035, $7.04 in 2040, and $14.21 in 2050) and rising ROIs (20.9% in 2030, 28.9% in 2032, 46.5% in 2035, 68.7% in 2040, and 204.6% in 2050).
Bullish sentiment appears in 2030, 2032, 2035, 2040, and 2050, signaling upside potential over the coming years, though the figures are estimates and not guarantees. The forecast includes a 0% ROI in 2026 and negative returns in the early years for some scenarios, underscoring that outcomes can vary significantly and depend on market conditions and company-specific factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.65, a min of $1.83, and a max of $4.17, with an ROI of 20.9% and bullish sentiment.
Forecasts indicate an average price of $2.65 in 2030 and $6.69 in 2050, with max values up to $4.17 (2030) and $14.21 (2050) and ROIs up to 204.6%. These are estimates, not guarantees, and depend on various market factors.
Yes. The 2050 max price is $14.21, so reaching $10 by 2050 is within the forecast range.
BHST's current price is $2.20 and its market capitalization is $49.76M.
The 30-day range is $1.71 to $2.83, with a current support at $1.92 and resistance at $3.31.
BioHarvest Sciences Inc. Community Discussion
0Share your BioHarvest Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.